Hematology & Oncology

University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.

Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.

Andrew Sweeney, now 35, was aware of his risk for colorectal cancer – his mother had had been diagnosed with it when she was 41. When he was 31, a CT scan at University of Michigan Health’s University Hospital revealed that Sweeney had a mass in his colon and potential metastases in his liver and lymph nodes. A colonoscopy confirmed that he had stage 4 colorectal cancer. After 1.5 years of chemotherapy, his care team began discussing how they could remove the damaged parts of Sweeney’s liver. They developed a colorectal cancer liver transplant protocol from a deceased donor and Sweeney was the first patient to undergo a liver transplant in Michigan for colon cancer. After minor recurrences of tumors in his lung in 2024, which were treated by surgery and radiation, his scans have been clear.

While their path was not smooth, faces and names from the past and present show the power of persistence

Around 1 in 6 older adults take aspirin as their primary method of preventing cardiovascular disease, despite stricter guidelines. For some patients, the benefit of aspirin may not outweigh the risk of bleeding.

The Advances in the Treatment of Stage III Non-Small Cell Lung Cancer (NSCLC) CME webinar, featuring a panel discussion with Michigan Medicine faculty from hematology and oncology, radiation oncology, pulmonary and critical care medicine, and thoracic surgery, will provide an update on the evolving landscape of NSCLC treatment.